TY - JOUR
T1 - Analysis of mechanisms by which NK cells acquire increased cytotoxicity against class I MHC-eliminated targets
AU - Sugawara, Shunji
AU - Abo, Toru
AU - Itoh, Hiroshi
AU - Kumagai, Katsuo
N1 - Funding Information:
I Supported in part by a Grant-in-Aid for Cancer Research from the Bioscience Program and a Grant-in-Aid for Cancer Research from the Ministry of Education, Science and Culture, Japan. * To whom correspondence should be addressed. ’ Abbreviations used: CTL, cytotoxic T lymphocytes; MHC, major histocompatibility complex; NK, natural killer; MNC, mononuclear cells; HLA, human leukocyte antigen; SSEA-1, stage-specific embryonic antigen-1.
PY - 1989/4
Y1 - 1989/4
N2 - Acid treatment, where cells are exposed to 0.2 M citric acid buffer at pH 3 for 2 min, was described in a previous paper to be a method which specifically eliminates class I MHC antigens from the membrane of viable cells. We applied this method to characterize functional roles of class I MHC antigens on the target cells in NK cell cytotoxicity. When NK target cells, U937, Molt-4, and Raji, were subjected to acid treatment, the treated cells lost their surface class I MHC antigens and became more sensitive to NK cell killing. On the other hand, the susceptibility of K562 cells which initially lacked class I MHC antigens did not significantly change after such treatment. We then examined the mechanism which enables NK cells to become more cytotoxic against class I MHC antigen-eliminated target cells. Single cell binding assay and cold target inhibition assay demonstrated that class I MHC antigen-eliminated target cells did not acquire high binding affinity to NK cells. However, the interaction between NK cells and class I MHC antigen-eliminated targets resulted in a greater increase in production of NKCF-like factor than did the interaction between NK cells and untreated targets. Class I MHC antigen-eliminated targets did not acquire high killer susceptibility to NKCF-like factor. The present study utilizing the acid treatment method confirmed that surface class I MHC antigens on the targets are important immunoregulatory molecules not only for cytotoxic T lymphocytes but also for NK cells and elucidated some of the underlying mechanisms.
AB - Acid treatment, where cells are exposed to 0.2 M citric acid buffer at pH 3 for 2 min, was described in a previous paper to be a method which specifically eliminates class I MHC antigens from the membrane of viable cells. We applied this method to characterize functional roles of class I MHC antigens on the target cells in NK cell cytotoxicity. When NK target cells, U937, Molt-4, and Raji, were subjected to acid treatment, the treated cells lost their surface class I MHC antigens and became more sensitive to NK cell killing. On the other hand, the susceptibility of K562 cells which initially lacked class I MHC antigens did not significantly change after such treatment. We then examined the mechanism which enables NK cells to become more cytotoxic against class I MHC antigen-eliminated target cells. Single cell binding assay and cold target inhibition assay demonstrated that class I MHC antigen-eliminated target cells did not acquire high binding affinity to NK cells. However, the interaction between NK cells and class I MHC antigen-eliminated targets resulted in a greater increase in production of NKCF-like factor than did the interaction between NK cells and untreated targets. Class I MHC antigen-eliminated targets did not acquire high killer susceptibility to NKCF-like factor. The present study utilizing the acid treatment method confirmed that surface class I MHC antigens on the targets are important immunoregulatory molecules not only for cytotoxic T lymphocytes but also for NK cells and elucidated some of the underlying mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=0024510456&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024510456&partnerID=8YFLogxK
U2 - 10.1016/0008-8749(89)90246-3
DO - 10.1016/0008-8749(89)90246-3
M3 - Article
C2 - 2702694
AN - SCOPUS:0024510456
SN - 0008-8749
VL - 119
SP - 304
EP - 316
JO - Cellular Immunology
JF - Cellular Immunology
IS - 2
ER -